Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda

Tuberculosis Clinical Trial

— TBcontact  

Official title:

Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda: An Open Cohort of Children <5 Years in Contact With Newly Diagnosed Adult TB Cases in Mbarara Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01492595
• Other study ID #: Epicentre/MBA/2011/TBcontact
• Status: Completed
• Phase: N/A
• First received: December 8, 2011
• Last updated: February 29, 2016
• Start date: April 2012
• Est. completion date: April 2014

Study information

• Verified date: February 2016
• Source: Epicentre
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Committee for the Protection of PersonnesUganda: National Council for Science and Technology
• Study type: Observational

Clinical Trial Summary

The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital

Description:

Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children <5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Contact tracing, investigation and prophylaxis of childhood contacts of adult TB cases are widely recommended but rarely practiced in developing countries. The World Health Organization recommends that all NTPs screen household contacts for symptoms of disease and offer isoniazid preventive therapy (i.e. daily isoniazid for at least 6 months) to children aged less than 5 years and to all HIV-infected children who are household contacts. In Mbarara, an area with a high incidence of TB, no program currently exists for the routine investigation of child contacts of adult pulmonary TB cases. Almost all child TB cases registered are found through the evaluation of symptomatic children, often long after the adult source-cases have been investigated and treated. The number of adult cases with pulmonary TB, together with the population structure in Mbarara (>50% of the total population being children) suggests that the number of childhood TB cases is probably higher than current hospital records indicate.

The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital. The study will also generate much needed data on the utility of simple symptom-based screening of child contacts for TB disease in areas where access to radiological examination and tuberculin skin test are limited and on the efficacy and safety of IPT, in a region with a significant problem of HIV co-infection.

Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study. Children will undergo a physical examination, chest Xray, tuberculin skin test and specimen collection in case of symptoms. Children will then be classified as active TB, TB infected and non infected cases. TB infected and non infected children will receive 6 months isoniazid prophylaxis with monthly monitoring of acceptability and tolerability. A final clinical assessment will be performed at 9 months. A total of 577 children contacts will be enrolled.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 281
• Est. completion date: April 2014
• Est. primary completion date: April 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 1 Month to 5 Years

Eligibility

Inclusion Criteria:

• Any child who has lived in the same household with the index case continuously for at least 2 weeks within the 3-month period immediately preceding the diagnosis of smear- positive or culture-positive TB in the index case.

• Informed consent signed by the parent or legal guardian

• Living within a 2-hour radius of Mbarara town

Exclusion Criteria:

• Child currently receiving anti-tuberculosis treatment

• Child has received a full course of anti-TB treatment within the last 6 months

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Tuberculosis

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
Epicentre	Mbarara University of Science and Technology, Medecins Sans Frontieres

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of <5 year-old child contacts classified as active TB disease, LTBI or no infection		Baseline	No
Secondary	Number of children <5 years exposed to TB in the household of adult index cases		Baseline	No
Secondary	Number of contacts identified as active TB basing on a symptom-based approach compared with those based on chest radiography		9 months	No
Secondary	Proportion of contacts with HIV co-infection classified as non infected, LTBI or active TB		9 months	No
Secondary	Median duration of exposure to symptomatic source case among the contacts in the various classes		Baseline	No
Secondary	Association of various risk factors with the final classification of contacts after assessment		9 months	No
Secondary	Proportion of children with LTBI successfully treated (prevented from developing active TB disease) among HIV-infected and uninfected children		9 months	No
Secondary	Proportion of children with no TB infection or disease successfully treated (prevented from developing active TB disease or LTBI)		9 months	No
Secondary	Proportion of adverse events on treatment of TB disease, LTBI and TB exposure		9 months	No
Secondary	Adherence to IPT regimens		9 months	No